What is normal blood pressure?

被引:12
作者
Freitag, MH
Vasan, RS
机构
[1] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA
[2] MetroW Med Ctr, Framingham, MA USA
[3] Boston Univ, Sch Med, Dept Epidemiol & Prevent Med, Boston, MA 02118 USA
关键词
blood pressure; hypertension; prevention; epidemiology; risk;
D O I
10.1097/00041552-200305000-00010
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review Given the continuous relations of blood pressure to cardiovascular risk, any definition of high blood pressure is arbitrary, and based on thresholds at which there is clear evidence that treatment benefits outweigh potential risks. This review examines what constitutes optimal blood pressure. Recent findings A recent report raised the possibility of an age- and sex-dependent threshold for risk associated with systolic blood pressure, questioning the use of a single threshold (such as 140/90 mmHg) for defining hypertension. Several subsequent studies have questioned this notion and reemphasized that lower blood pressure levels are associated with less morbidity and mortality even within the nonhypertensive range. A recent meta-analysis confirmed that a blood pressure of 115/75 mmHg is associated with minimal vascular mortality and likely constitutes optimal blood pressure. Such blood pressure levels are infrequent in westernized societies. The target blood pressure goal for treated hypertensives is higher at 140/90 mmHg but is infrequently achieved. Select individuals at high absolute risk of cardiovascular disease events and/or with specific conditions (notably diabetes, renal insufficiency and prior vascular disease) may benefit from blood pressure lowering below this threshold. Summary At a population level, a blood pressure of 115/75 mmHg seems optimal because it is associated with minimal vascular risk. Over half of all hypertensives do not have their blood pressure controlled underscoring the challenges facing health care providers. Efforts should be strengthened for the primary prevention of hypertension and the promotion of optimal blood pressure through lifestyle measures.
引用
收藏
页码:285 / 292
页数:8
相关论文
共 66 条
[11]   TRENDS IN THE PREVALENCE, AWARENESS, TREATMENT, AND CONTROL OF HYPERTENSION IN THE ADULT US POPULATION - DATA FROM THE HEALTH EXAMINATION SURVEYS, 1960 TO 1991 [J].
BURT, VL ;
CUTLER, JA ;
HIGGINS, M ;
HORAN, MJ ;
LABARTHE, D ;
WHELTON, P ;
BROWN, C ;
ROCCELLA, EJ .
HYPERTENSION, 1995, 26 (01) :60-69
[12]  
Chalmers J, 1999, J HYPERTENS, V17, P151
[13]   BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT [J].
COLLINS, R ;
PETO, R ;
MACMAHON, S ;
HEBERT, P ;
FIEBACH, NH ;
EBERLEIN, KA ;
GODWIN, J ;
QIZILBASH, N ;
TAYLOR, JO ;
HENNEKENS, CH .
LANCET, 1990, 335 (8693) :827-838
[14]  
CRUICKSHANK JM, 1987, LANCET, V1, P581
[15]   Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].
Dahlöf, B ;
Devereux, RB ;
Kjeldsen, SE ;
Julius, S ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristiansson, K ;
Lederballe-Pedersen, O ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H .
LANCET, 2002, 359 (9311) :995-1003
[16]   Pulse pressure and cardiovascular disease-related mortality - Follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT) [J].
Domanski, M ;
Mitchell, G ;
Pfeffer, M ;
Neaton, JD ;
Norman, J ;
Svendsen, K ;
Grimm, R ;
Cohen, J ;
Stamler, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (20) :2677-2683
[17]   Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium [J].
Fagard, RH ;
Van den Enden, M ;
Leeman, M ;
Warling, X .
JOURNAL OF HYPERTENSION, 2002, 20 (07) :1297-1302
[18]   BLOOD-PRESSURE AND MORTALITY AMONG MEN WITH PRIOR MYOCARDIAL-INFARCTION [J].
FLACK, JM ;
NEATON, J ;
GRIMM, R ;
SHIH, J ;
CUTLER, J ;
ENSRUD, K ;
MACMAHON, S .
CIRCULATION, 1995, 92 (09) :2437-2445
[19]   Control of hypertension and risk of stroke recurrence [J].
Friday, G ;
Alter, M ;
Lai, SM .
STROKE, 2002, 33 (11) :2652-2657
[20]   Age-related bias in the management of hypertension: A national survey of physicians' opinions on hypertension in elderly adults [J].
Hajjar, I ;
Miller, K ;
Hirth, V .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2002, 57 (08) :M487-M491